5,11-dimethyl-5h-indolo(2,3-b)quinoline has been researched along with mitoxantrone in 1 studies
Studies (5,11-dimethyl-5h-indolo(2,3-b)quinoline) | Trials (5,11-dimethyl-5h-indolo(2,3-b)quinoline) | Recent Studies (post-2010) (5,11-dimethyl-5h-indolo(2,3-b)quinoline) | Studies (mitoxantrone) | Trials (mitoxantrone) | Recent Studies (post-2010) (mitoxantrone) |
---|---|---|---|---|---|
11 | 0 | 5 | 4,555 | 1,042 | 1,004 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Godlewska, J; Kaczmarek, L; Luniewski, W; Peczynska-Czoch, W; Piskozub, M; Switalska, M; Wietrzyk, J | 1 |
1 other study(ies) available for 5,11-dimethyl-5h-indolo(2,3-b)quinoline and mitoxantrone
Article | Year |
---|---|
New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Topics: Animals; Antineoplastic Agents; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fibroblasts; HL-60 Cells; Humans; Indoles; Jurkat Cells; Male; MCF-7 Cells; Mice; Molecular Structure; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2012 |